We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to Amgen for Enbrel Ad
FDA Issues Warning Letter to Amgen for Enbrel Ad
April 6, 2005
The FDA earlier this year issued a warning letter to Amgen for running a television promotion of its psoriasis drug Enbrel that includes an unsubstantiated claim.